Industry News
Potential new Alzheimer's drugs advancing in clinical trials
The hypothesis that amyloid-beta blockers is the cause of Alzheimer's disease is being put to the test. [ + ]
Daunting challenges ahead for genetics: J. Craig Venter
10 years on from the Human Genome Project challenges remain in linking genotypes to phenotypes and in data quality. [ + ]
Australian biotech market watch 07/04/10
News of a further awakening economy and the possibility of more interest rate rises has seen the All Ordinaries nudge up another 11.5 points in morning trading to 4,985, primarily driven by IT and utilities. [ + ]
Gold nanoparticles used to detect melamine in milk
The interaction between gold nanoparticles and melamine has been found to cause a dramatic colour change indicating the presence of melamine in milk.
[ + ]Nerve growth factor could yield new breed of painkillers
Nerve growth factor an important target for new painkillers, but it's not without its risks, says analysts. [ + ]
Australian biotechs to benefit from US health care bill
The new 12 year exclusive market protection on new biologics a boon for biotechnology in Australia. [ + ]
Polymer-based method for creating photovoltaic devices
Chemists have identified a polymer-based system that may improve the efficiency of photovoltaic devices.
[ + ]New discovery is a significant boost to cancer research
Synthetic derivatives UDP-Galactose have been found to block the activity of glycosyltransferases and may have a significant role in the treatment of cancer, inflammation and infection.
[ + ]Win for personalised medicine in US DNA patent case
In a ruling that will most definitely advance the development of personalised, molecular medicine and the practice of molecular pathology, a US district court has found against gene patenting.
[ + ]Bias in scientific publishing rife
A reluctance to publish negative results is leading to a troubling bias in scientific journals. [ + ]
Songbird genome gives insight into memory and speech
The genome of the zebra finch is helping us understand how we learn how to speak. [ + ]
Phosphagenics goes global
Phosphagenics signs global agreement for use of transdermal insulin in pets. [ + ]
Clinuvel to commence trial of afamelanotide in the US
Phase II trial to test effectiveness of afamelanotide in treating erythropoietic protoporphyria. [ + ]
Living Cell Technology to begin phase II diabetes trial
New clinical trial for type I diabetes treatment using xenotransplantation of pig cells to begin in New Zealand. [ + ]
Bio-marker for MS - the start of personalised medicine
Researchers at the University of Alabama at Birmingham have found the first bio-marker for multiple sclerosis (MS) that might predict which patients will respond to a standard therapy and which will not.
[ + ]
